Cargando…
A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia
Acute myeloid leukemia (AML) arises from the cells of myeloid lineage and is the most frequent leukemia type in adulthood accounting for about 80% of all cases. The most common treatment strategy for the treatment of AML includes chemotherapy, in rare cases radiotherapy and stem cell and bone marrow...
Autores principales: | Aru, Başak, Pehlivanoğlu, Cemil, Dal, Zeynep, Dereli-Çalışkan, Nida Nur, Gürlü, Ege, Yanıkkaya-Demirel, Gülderen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895857/ https://www.ncbi.nlm.nih.gov/pubmed/36742324 http://dx.doi.org/10.3389/fimmu.2023.1108200 |
Ejemplares similares
-
Comparison of Laboratory Methods for the Clinical Follow Up of Checkpoint Blockade Therapies in Leukemia: Current Status and Challenges Ahead
por: Aru, Basak, et al.
Publicado: (2022) -
Testosterone Propionate Promotes Proliferation and Viability of Bone Marrow Mesenchymal Stem Cells while Preserving Their Characteristics and Inducing Their Anti-Cancer Efficacy
por: Aru, Başak, et al.
Publicado: (2023) -
Evaluation of histone deacetylase inhibitor substituted zinc and indium phthalocyanines for chemo- and photodynamic therapy
por: Aru, Başak, et al.
Publicado: (2021) -
A Translational Study of a Silicon Phthalocyanine
Substituted with a Histone Deacetylase Inhibitor for Photodynamic
Therapy
por: Aru, Başak, et al.
Publicado: (2020) -
Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2023)